Naho Tateshita

Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.

Takashi Nakamura, H. Harashima, H. Akita, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine.

Hiroki Tanaka, H. Akita, Kota Tange, 2019, Journal of controlled release : official journal of the Controlled Release Society.

An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses

Masatoshi Maeki, Hiroki Tanaka, H. Akita, 2023, ACS nano.

Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.

Takashi Nakamura, H. Harashima, H. Akita, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.